4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001831755-26-000002
Options or other derivatives
- Chief Legal Officer acquired 295,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| LaCascia Michael Chief Legal Officer | 2026-01-30 | Grant or award · Stock option (right to buy) | +295,000 | $5.71 | $1,684,450 | 295,000 | D |
Loading xslF345X05/primarydocument.xml…